HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Carla Emiliani Selected Research

Melanoma (Melanoma, Malignant)

12/2020Lipidomic analysis of cancer cells cultivated at acidic pH reveals phospholipid fatty acids remodelling associated with transcriptional reprogramming.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Carla Emiliani Research Topics

Disease

12Neurodegenerative Diseases (Neurodegenerative Disease)
08/2022 - 10/2003
9Alzheimer Disease (Alzheimer's Disease)
10/2022 - 10/2003
8Neoplasms (Cancer)
03/2024 - 05/2009
4Parkinson Disease (Parkinson's Disease)
10/2022 - 11/2009
4Sandhoff Disease (Sandhoff's Disease)
03/2022 - 11/2005
3Globoid Cell Leukodystrophy (Krabbe Disease)
02/2024 - 01/2022
3Inborn Genetic Diseases (Disease, Hereditary)
03/2023 - 08/2014
3Lysosomal Storage Diseases (Lysosomal Storage Disease)
03/2022 - 04/2015
3GM2 Gangliosidoses (GM2 Gangliosidosis)
06/2019 - 06/2002
2COVID-19
01/2023 - 06/2021
2Tuberous Sclerosis (Bourneville's Disease)
05/2018 - 01/2017
2Metachromatic Leukodystrophy (Sulfatide Lipidosis)
01/2014 - 05/2005
1Colonic Neoplasms (Colon Cancer)
04/2024
1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
03/2024
1Sickle Cell Anemia (Hemoglobin S Disease)
01/2023
1Anemia
01/2023
1Hemolysis
01/2023
1Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
10/2022
1Huntington Disease (Huntington's Disease)
10/2022
1Glioblastoma (Glioblastoma Multiforme)
08/2022
1Metabolic Diseases (Metabolic Disease)
03/2022
1Gliosis
01/2022
1Psoriasis (Pustulosis Palmaris et Plantaris)
01/2022
1Drug-Induced Abnormalities (Abnormalities, Drug Induced)
11/2021
1Breast Neoplasms (Breast Cancer)
12/2020
1Melanoma (Melanoma, Malignant)
12/2020
1Inflammation (Inflammations)
09/2020
1Parkinsonian Disorders (Parkinsonism)
04/2020
1Adenocarcinoma
04/2020
1Autoimmune Diseases (Autoimmune Disease)
08/2019
1Neuroblastoma
03/2019
1Cerebrovascular Disorders (Cerebrovascular Occlusion)
01/2019
1Central Nervous System Cavernous Hemangioma
01/2019
1Pathologic Processes
06/2018
1Carcinogenesis
05/2018
1Neurologic Manifestations (Neurological Manifestations)
05/2018
1Cysts
10/2017
1Cognitive Dysfunction
08/2017
1Persistent Infection
06/2017
1Astrocytoma (Pilocytic Astrocytoma)
01/2017
1Clinical Deterioration
04/2015
1Glycogen Storage Disease Type II (Pompe's Disease)
04/2015
1Sphingolipidoses (Sphingolipidosis)
08/2014

Drug/Important Bio-Agent (IBA)

12Proteins (Proteins, Gene)FDA Link
01/2023 - 01/2008
8EnzymesIBA
02/2024 - 06/2002
7LipidsIBA
03/2024 - 01/2015
5Biomarkers (Surrogate Marker)IBA
03/2024 - 03/2013
4Hexosaminidases (Hexosaminidase)IBA
01/2015 - 11/2005
3GalactosylceramidaseIBA
02/2024 - 01/2022
3Sirolimus (Rapamycin)FDA Link
02/2024 - 05/2016
3PolymersIBA
08/2022 - 01/2019
3Glycoside Hydrolases (Endoglycosidases)IBA
03/2019 - 10/2003
3TOR Serine-Threonine KinasesIBA
01/2019 - 05/2016
3beta-N-AcetylhexosaminidasesIBA
02/2010 - 06/2002
2AntioxidantsIBA
04/2024 - 04/2020
2Psychosine (Galactosylsphingosine)IBA
02/2024 - 01/2022
2poly(lactide) (polylactic acid)IBA
03/2022 - 04/2015
2Hexosaminidase A (Hex A)IBA
03/2022 - 06/2014
2Phospholipids (Phosphatides)FDA LinkGeneric
01/2022 - 12/2020
2Fatty Acids (Saturated Fatty Acids)IBA
12/2020 - 04/2020
2RotenoneIBA
04/2020 - 07/2019
2MTOR InhibitorsIBA
01/2019 - 05/2016
2Mechanistic Target of Rapamycin Complex 1IBA
05/2018 - 01/2017
2trans-sodium crocetinate (crocetin)IBA
05/2018 - 01/2017
2G(M2) Ganglioside (Ganglioside GM2)IBA
08/2014 - 11/2005
2Cerebroside-Sulfatase (Arylsulfatase A)IBA
01/2014 - 05/2005
1Drinking WaterIBA
02/2024
1Hemoglobins (Hemoglobin)IBA
01/2023
1CytokinesIBA
01/2023
1Oxygen (Dioxygen)IBA
01/2023
1Mutant Proteins (Protein, Mutant)IBA
10/2022
1Ustekinumab (CNTO 1275)FDA Link
01/2022
1LithiumIBA
01/2022
1Adalimumab (Humira)FDA Link
01/2022
1secukinumabIBA
01/2022
1Amiodarone (Amiodarona)FDA LinkGeneric
11/2021
1Membrane LipidsIBA
12/2020
1Amyloid (Amyloid Fibrils)IBA
09/2020
1Glucose (Dextrose)FDA LinkGeneric
09/2020
1ApolipoproteinsIBA
09/2020
1Protein AggregatesIBA
04/2020
1CurcuminIBA
04/2020
1delta(6)-hexadecenoic acidIBA
04/2020
1VaccinesIBA
08/2019
1NeurotoxinsIBA
07/2019
1MicroRNAs (MicroRNA)IBA
06/2019
1GlycosphingolipidsIBA
03/2019
1EverolimusFDA Link
01/2019
1Immunosuppressive Agents (Immunosuppressants)IBA
01/2019
1RNA (Ribonucleic Acid)IBA
06/2018
1Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA
10/2017
1Cysteine Proteases (Cysteine Protease)IBA
06/2017
1AcidsIBA
04/2015
1alpha-Glucosidases (Acid Maltase)IBA
04/2015
1GlycogenIBA
04/2015
1GangliosidesIBA
01/2015
1GalactosidasesIBA
01/2015
1SphingolipidsIBA
08/2014
1Pyrimethamine (Daraprim)FDA Link
08/2014

Therapy/Procedure

4Therapeutics
01/2019 - 08/2014